their increased proliferation rate (P < 0"05), but did not affect neuronal differentiation. A significant (P < 0"05) increase in cell proliferation was consistently observed in PC12 cells supplemented with low concentrations of Tat (5 to 25 ng/ml), whereas neuronal differentiation was hardly affected by exogenous Tat. Our data strongly suggest that Tat exerts a complex influence on the proliferation and differentiation of PC12 cells, and this might help in increasing understanding of the pathogenesis of the frequent neurological disorders observed in AIDS patients.
Introduction
The protein encoded by the tat gene of human immunodeficiency virus type 1 (HIV-1) plays an essential role in viral replication (Rosen et al., 1986; Cullen, 1986; Wright et al., 1986) , acting on the cis-acting sequenceresponsive TAR element, located at the 5' end of all viral mRNAs (Rosen et al., 1985) . In addition to this action on the viral genome, Tat protein, by analogy with the tax gene of human T cell leukaemia virus type 1 (Kim et al., 1991) , is able to trans-activate strategic cellular genes, such as those encoding tumour necrosis factor-fl (Sastry et al., 1990 , Buonaguro et al., 1992 , interleukin-6 (IL-6; Rezai et al., 1991) and transforming growth factor-ill (Zauli et al., 1992) . Moreover, recent findings demonstrated that Tat protein can act as an exogenous growth factor, since it can be rapidly taken up by different cell types (Frankel & Pabo, 1988) , and displays either stimulatory (Ensoli et al., 1990) or inhibitory (Viscidi et al., 1989) effects on cell proliferation, depending on the cell type considered and the concentrations employed.
Neurological disorders are frequently observed in HIV-l-infected individuals (Prince et al., 1988) . It has been suggested that infected peripheral blood monocytes, which are the progenitors of microglial cells, are responsible for introduction of HIV-1 to the central nervous system. Microglial cells appear to carry the greatest viral load (Merrill & Chen, 1991) , whereas a direct infection of neuronal cells has not yet been clearly demonstrated in vivo. However, increasing evidence suggests that uninfected neuronal cells can be influenced by both inhibitory cytokines (Wahl et al., 1991) and viral products, such as the envelope glycoprotein gpl20 (Brenneman et al., 1988) , released by neighbouring infected cells.
In this paper, our aim was to evaluate the effect of Tat protein on the proliferation and differentiation of neuronal cells. For this purpose, we chose to investigate the effect of Tat on PC12 rat pheochromocytoma cells, which have the unique capability to differentiate into sympathetic-like neurons upon treatment with nerve 0001-1830 © 1993 SGM growth factor (NGF) or IL-6 (Greene, 1978; Rudkin et al., 1989; Satoh et al., 1988) .
Methods
Transfection of PC12 cells' with HIV-I tat gene. Pheochromocytoma PCl2 cells (Greene & Tischler, 1976) were kindly provided by Dr Lloyd Greene (Columbia University, N.Y., U.S.A.). Cells were usually grown in tissue culture flasks in Dulbecco's MEM (D-MEM) with 10% heatinactivated horse serum (HS, Gibco) and 5 % heat-inactivated fetal bovine serum (FBS, Gibco) at 37 °C in a fully humidified atmosphere of 7.5% CO 2 in air. PC12 cells were transfected with the expression vector pRPneo-c-Tat/S (Grossi et al., 1988) , kindly provided by Professor Barbanti-Brodano (Institute of Microbiology, University of Ferrara, Italy), using the liposome kit Transfectam (Promega). The pRP neo-c-Tat/S vector contains the bacterial gene neo, which confers resistance to the aminoglycoside antibiotic G418 and the cDNA of HIV-1 tat gene in the sense orientation, both under the control of simian virus 40 (SV40) early region promoter and polyadenylation sequences. Unlike in human cells where the vector remains episomal, in rat cells it integrates into genomic DNA. PC 12 cells were also mocktransfected with pRPneo-c vector alone which does not contain the HIV-1 tat gene.
Assay of chloramphenicol acetyltransjerase (CAT) activity in Tatpositive and mock-transfected PC12 cell clones.
To evaluate the production of biologically active Tat protein, different tat-transfected and mock-transfected PCI2 cell clones were transiently cotransfected with the plasmid pTZIIICAT, containing the long terminal repeat (LTR) promoter of HIV-1 in front of the bacterial CAT gene (Rosen et al., 1985) , using Transfectam. The CAT assay was performed as described by Gorman et al. (1982) . Briefly, cell extracts were made 48 to 72 h after transfection by sonicating washed, centrifuged cells in 100 lal of 0.25 M-Tris-HC1 pH 7.8. After this the cells were centrifuged for 15 min in an Eppendorf microfuge at 4 °C, the supernatants were then removed and assayed for enzyme activity. The assay mixture had a final volume of 100 lal of distilled water and contained 100 lag of cell extract, 0-25 laCi of [14C]chloramphenicol (50 laCi/mmol, DuPont) and 2 lal of 40 mM-acetyl coenzyme A. Controls were used that contained CAT instead of cell extract. After a 60 min reaction, an estimate of the levels of protein was performed by scraping the spots from each plate and counting the radioactivity in a t-counter. Tat protein detection by in situ immunoeytochemistry. PC12 cells, plated on coverslips, were processed for immunocytochemistry after 3 days of culture, using fixation with 4 % freshly made paraformaldehyde in 1 x PBS pH 7.3 followed by permeabilization with cold (-20 °C) methanol. Non-specific binding of antibodies was blocked by preincubating samples with 1 x PBS, 2 % BSA, 5 % NGS (PBN buffer) for l h at 37 °C. Primary monoclonal or rabbit polyclonal anti-Tat antibody (American Bioteclmologies) were used at 1:20 and 1:25 dilution, respectively, in PBN buffer. After 3 h at 37 °C, coverslips were washed three times with 1 x PBS and incubated for 1 h at 37 °C with a goat anti-rabbit or an anti-mouse IgG antibody, conjugated with alkaline phosphatase. In negative controls, primary antibodies were omitted. Alkaline phosphatase was then detected as previously described (Martelli et al., 1991) .
Treatment of PC12 cells with recombinant Tat protein or NGF.
Fulllength recombinant Tat protein, produced in Escherichia colt (American Biotechnologies) , was stored at -70 °C with 0-1 mM-DL-dithiothreitol to prevent oxidation and resuspended in PBS containing 0.1% BSA (Sigma) before use. The Tat protein preparations used in this study were shown to be free of endotoxin contamination by using the limulus amoebocyte lysate test (Whittakers M.A. Bioproducts). PC12 cells (50 x 108) were pelleted in an Eppendorf tube and supplemented with serial concentrations (from 1 ng to 1 lag/ml) of Tat in 50 lal of D-MEM plus 1% HS for 2 h at 37 °C. Cells were then seeded in plastic Petri dishes at the concentration of 5 x 10*/cm 2 in a final volume of 3 ml of D-MEM containing 10% HS plus 5% FCS. In parallel, the different Tat protein concentrations were pre-incubated with 5 lag of a monoclonal anti-Tat antibody, 1 : 100 dilution of a polyclonal anti-Tat antibody, or 1 : 100 dilution of control anti-mouse polyclonal antibody for l h at 37 °C before being added to PC12 cells. 5-bromo-2-deoxyuridine (BrdU) incorporation was evaluated after 24 to 72 h of culture.
In some experiments, PC12 cells were seeded in culture at low density (5 x 103/ml) in the absence or presence of 100 ng/ml of purified murine NGF (U.B.I.). Every 3 days, fresh medium containing NGF was added to the cultures. After 1, 5 and 10 days of culture, cell proliferation and differentiation were evaluated by measuring BrdU incorporation and visualizing neurite outgrowth using a light microscope, respectively.
Evaluation of BrdU uptake. Tat-positive and mock-transfected PC12 cells were seeded at low density (5 x 103/cm 2) on poly(L-lysine)-and collagen-coated glass coverslips in six multiwell plates. In some experiments, 5 lag/ml of a monoclonal anti-Tat antibody (American Biotechnologies) or 1 : 100 dilution of a control anti-mouse polyclonal antibody were added to the culture medium of tat-transfected or mocktransfeeted PC12 cell clones. After 24 h of culture, 100 mM-BrdU was added to each plate for 30 rain, and then samples were treated as previously described (Neri et al., 1992) . Briefly, cells were fixed in 4 % paraformaldehyde/Dulbecco's PBS pH 7.3 for 30 rain at room temperature, washed in PBS and incubated with a 1:10 dilution of a ftuorescein isothiocyanate (FITC)-conjugated anti-BrdU antibody (Becton-Dickinson). Coverslips were mounted in glycerol-PBS-1,4-diazabicyclo-2,2,2-octane and slides were examined under a Zeiss Axiophot microscope.
Criteria of morphological differentiation into sympathetic-like neurons.
The proportion of neurite-bearing cells was determined by the method described by Rydel & Greene (1987) . A cell was considered differentiated when neurite length reached at least twice that of the cell body (i.e. 20 lam). Neurite length was determined using printed micrographs on at least 100 randomly selected cells.
Statistical analysis.. The results were expressed as mean+s.D., obtained from three or more experiments performed in duplicate. Statistical analysis was performed using the two-tailed Student's t-test.
Results

Establishment of tat-positive PC12 cell clones producing different amounts of Tat
To examine the role of the HIV-1 Tat protein in proliferation and differentiation of neuronal cells, we first developed several PC12 clones that were constitutively expressing Tat p l a y i n g an increase in H I V -1 L T R t r a n s c r i p t i o n a l activity were selected for f u r t h e r studies (Fig. 1) . E x p r e s s i o n o f the H I V -1 tat gene was also c o n f i r m e d in tat-positive P C 1 2 cells by direct v i s u a l i z a t i o n o f T a t p r o t e i n by i m m u n o h i s t o c h e m i s t r y w i t h ceils being p r o b e d w i t h a m o n o c l o n a l a n t i -T a t a n t i b o d y (Fig. 2) . A n intense labelling was o b s e r v e d in b o t h n u c l e a r a n d c y t o p l a s m i c c o m p a r t m e n t s .
Increased proliferation rate of tat-positive PC12 cell clones
T h e extent o f cell p r o l i f e r a t i o n was d e t e r m i n e d by m e a n s o f a B r d U i n c o r p o r a t i o n assay (Neri et al., 1992) . A f t e r 24 h o f culture, tat-positive P C 1 2 cell clones no. 1 a n d 2 s h o w e d a significant ( P < 0"05) increase in B r d U u p t a k e w i t h respect to m o c k -t r a n s f e c t e d P C 1 2 cells (Table 1) * Data are expressed as mean±s.D, of four separate experiments performed in duplicate. Tat (5 to 50 ng/ml) induced a statistically significant (P < 0-05) increase in PC12 cell proliferation.
of Tat (Fig. 1 , clones no. 1, 2 and 3) displayed a higher proliferation rate with respect to mock-transfected PC 12 cell clones, untreated PC12 cells, and also tat-positive PC12 cell clones showing lower Tat expression (Fig. 1 , clones no. 4 and 5).
The differential growth rate observed in tat-positive PC 12 cell clones expressing various levels of Tat strongly suggested that Tat was directly involved in the increased proliferation observed in tat-positive PC12 cells. This hypothesis was further supported by the demonstration that addition of 5 lag/ml of anti-Tat antibody to the culture medium of PCI2 cell clones was able to reduce significantly (P < 0.05) the increased proliferation rate of tat-positive PC12 cells to levels comparable to those of mock-transfected PC12 cells ( Table 2) .
Ability of recombinant Tat protein to promote proliferation of PC12 cells
We then tried to elucidate whether recombinant Tat protein was able to increase proliferation of PC12 cells also. PC12 cells were treated with serial concentrations (from 1 ng/ml to 1 lag/ml) of recombinant Tat (Table 3) . After 24 h of culture with serum a significant (P < 0-05) increase in cell proliferation was observed in cultures supplemented with 10 to 50 ng/ml of Tat. On the other hand, higher concentrations (0.1 to 1 gg/ml) of Tat were unable to promote PC12 cell growth and in the presence of 1 lag/ml of Tat an increase in cell death was observed using trypan blue dye exclusion (data not shown). The influence of the Tat protein on PC12 cell proliferation was specific, since pre-treatment of Tat protein with 5 gg of a monoclonal anti-Tat antibody (Table 3) completely blocked the Tat-mediated increase of cell proliferation.
Partial morphological differentiation of tat-positive PC12 cell clones into sympathetic-like neurons
Untreated PC12 cells typically showed a round shape (Fig. 3 a) , which resembled adrenal medullary chromaffin cells (Greene, 1978) and did not change with the culture conditions (cell density, days of culture, etc.). On the other hand, a long-term exposure to 100 ng/ml of NGF was able to induce an initial neurite outgrowth after only 1 day of culture (Fig. 3 b) , which became more evident after 3 to 5 days of culture (Fig. 3c) . After 10 to 12 days of culture, NGF-treated PC12 cells were converted into fully differentiated sympathetic-like neurons (Fig. 3 d) .
Mock-transfected PC12 cell clones showed a morphology which was indistinguishable from that of untreated PC12 cells. On the other hand, tat-positive cell lines showed cell flattening and production of cytoplasmic extensions (spiking) within 24 h after seeding in culture (Fig. 3e) and after 3 to 5 days of low-density culture the development of neurite-like processes was clearly evident (Fig. 3f) . Nevertheless, at variance with (c) NGF-treated PC12 cells, the different tat-positive PC12 cell clones continued to grow in spite of their partial morphological differentiation into sympathetic-like neurons. After 10 to 12 days of culture, a confluent monolayer of cells was usually observed, and the neuritelike processes were no longer clearly distinguishable (Fig.  3g) . The percentage of cells incorporating BrdU only slightly decreased with time in tat-positive PC 12 cell lines and a significant fraction of cells was still proliferating after 10 days of culture (Table 4) . On the contrary, the proportion of NGF-treated PC12 cells incorporating BrdU decreased progressively and dropped near to 0 % after 10 days of culture when full morphological differentiation was achieved.
The addition of 100 ng/ml of recombinant Tat to PC12 cells induced some very early morphological changes, such as cell flattening and production of cytoplasmic extensions, but was unable to induce a clearcut morphological differentiation with emission of neurite-like processes, like those observed in tat-positive PC12 cells (Fig. 3f) . Moreover, whereas the addition of 5 gg/ml of a monoclonal anti-Tat antibody to the culture medium of tat-positive PC12 cell clones significantly reduced their proliferation rate (Table 2) , it did not affect the differentiated morphology at all (data not shown).
Discussion
The clinical course of AIDS is frequently complicated by multiple neurological disorders (Merrill & Chen, 1991) . The evidence of a significant correlation between the levels of HIV-1 expression in the brain and clinical severity of the neurological complications (Weiser et al., 1990) strongly suggests that HIV-1 is directly involved in central nervous system pathology. Since evidence of a direct infection of neuronal cells in vivo is still lacking, it is conceivable that neuronal cell functions can be affected indirectly by cellular and viral proteins released by infected microglial cells. In this respect, it is noteworthy that the regulatory Tat protein of HIV-1 can be actively secreted by infected cells (Ensoli et al., 1990) and affects the proliferation of different cell types (Viscid± et al., 1989; Ensoli et al., 1990) , acting as a viral growth factor.
In this study, we evaluated the influence of Tat on the proliferation and differentiation of the rat pheochromocytoma PCt2 cell line. Several tat-positive PC12 cell clones showed a significantly increased proliferation rate with respect to mock-transfected PC12 cells, and this increase in cell proliferation correlated well with the level of Tat expression by the different tat-positive PC12 cell clones. A similar increase in cell proliferation was also observed when low doses of recombinant Tat (5 to 25 ng/ml) were added to PC12 cells.
Our data on PC12 neuronal cells expand previous observations of Ensoli et al. (1990 Ensoli et al. ( , 1993 , demonstrating that the growth-promoting activity of low doses of Tat is not confined to Kaposi's sarcoma cells but also involves a completely different cell type of neuronal origin. Moreover, it is remarkable that Tat has the ability to induce a partial morphological differentiation of PC12 cells into sympathetic-like neurons, although in tatpositive PC 12 cell clones proliferation never stopped and eventually a confluent monolayer was reached.
To our knowledge, HIV-1 Tat is the first molecule to be found that can stimulate cell proliferation and induce morphological differentiation of PC12 cells at the same time. Typically, when PC12 cells are induced to differentiate by addition of cellular growth factors, such as NGF or IL-6, a parallel progressive decrease in cell proliferation has always been reported (Greene, 1978; Rudkin et at., 1989; Satoh et at., 1988) . Conversely, cellular growth factors that are able to increase the proliferation rate of PC12 cells, such as EGF (Huff & Guroff, 1979) , never induce morphological changes characteristic of differentiated sympathetic-like neurons, similar to those observed in the presence of Tat.
However, our data suggest that Tat could influence proliferation and differentiation of PC12 cells through different pathways. In fact, the addition of recombinant Tat to PC12 cells significantly stimulated cell proliferation but had little effect on neuronal differentiation, whereas the addition of anti-Tat monoclonal antibody to the culture medium of tat-positive PC12 cell clones almost completely blocked their increased proliferation but did not affect their differentiated morphology. A possible explanation for our findings is that Tat, continuously produced and released in low amounts by tat-positive cell clones, could promote cell growth by signal transduction after interaction with specific integrin receptors, whereas it could induce cell differentiation by direct trans-activation of strategic cellular genes. Were this the case this could greatly improve our understanding of the effect of Tat on neuronal functions and the process of neuronal differentiation. The recent report of Taylor et al. (1992) , showing the ability of Tat to activate the expression of genes coding for extracellular matrix proteins in glioblastoma cells, is particularly noteworthy since the process of neuronal differentiation involves profound changes of the cytoskeleton. Moreover, it has been previously demonstrated that Tat stimulates human B lymphocyte cell lines (Rezai et al., 1991) and normal monocytes (Zauli et al., 1993) to produce IL-6, which is able to induce neuronal differentiation of PC12 cells (Satoh et al., 1988) . Tat-positive PC12 cell clones described in this study represent a unique model for studying the complex influences of Tat on cell proliferation and differentiation.
In conclusion, our data demonstrate that Tat protein can markedly influence the functions of neuronal cells and suggest that an active release of Tat by infected cells in the central nervous system could be involved in the pathogenesis of the different neurological manifestations frequently observed in HIV-l-infected individuals.
